Preclinical In-vivo Imaging Market size and growth: The globalPreclinical In-vivo Imaging market has been estimated at USD 714.17 million in 2018 and is projected to reach USD 944.95 million by 2023, ata CAGR of 5.6% during the forecast period.
Preclinical In-vivo Imaging Market overview:
Preclinical imaging (In-VIVO) is used in live animal research for drug development. Preclinical imaging is further used to monitor the treatment response for early indications of efficacy. The technological development of in vivo imaging provides an opportunity for studying disease at the molecular level in a quantitative way. In vivo imaging acts as a bridge between in vitro exploratory and in vivo clinical research which facilitates the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key disease areas targeted with in vivo preclinical imaging are cancers, autoimmune diseases, neurological disorders, and cardiovascular diseases. Use of preclinical imaging in cancer is about 70% which is followed by autoimmune diseases and neurological disorders which accounts for 36% and 32%, respectively.
To know more, read @ https://www.marketdataforecast.com/market-reports/preclinical-in-vivo-imaging-market